https://www.prnewswire.com/news-releases/metastatic-non-small-cell-lung-cancer-market-forecast-analysis-and-with-focus-on-its-immunemolecular-biomarker-types-pd-l1-egfr-kras-alk-braf-met-ros-1-her2-ret-fusion-and-ntrk123-gene-fusion--delveinsight-301998881.html
0
0
Metastatic Non-small Cell Lung Cancer Market Forecast Analysis and with Focus on its Immune/Molecular Biomarker Types: PD-L1, EGFR, KRAS, ALK, BRAF, MET, ROS-1, HER2, RET fusion, and NTRK1/2/3 Gene fusion | DelveInsight - PR Newswire
11/28/23 at 10:06pm
Organization
PRNewswire
Authors
Details
59 words
Summarize
Cancer Health Pharmaceuticals & Biotech Metastatic Non-small Cell Lung Cancer Biomarker Types Gene fusion ROS1 PD-L1 EGFR KRAS BRAF NTRK1 Metastatic Non-small Cell Lung Cancer Market Insights PRNewswire
/PRNewswire/ -- DelveInsight's Metastatic Non-small Cell Lung Cancer Market Insights report includes a comprehensive understanding of current country-specific...
Create an account or login to join the discussion